Nexentis Technologies Inc.
NXTS Nasdaq
SEC CIK 1789192
Follow Nexentis Technologies
Weekly email: filings, results, news
Net income
−$11.1M
−147.2% vs same quarter last year
EPS, diluted
−$13.66
+69.1% vs same quarter last year
Operating cash flow
−$539K
−2.1% vs same quarter last year
Operating income
−$1.9M
+28.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$4M |
| FY24 | $210K | −$5.2M |
| FY23 | $263K | −$6.5M |
| FY22 | $394K | −$5.7M |
| FY21 | $438.1K | −$4.8M |
| FY20 | $232.3K | −$1.6M |
| FY19 | $175.8K | −$2M |
| FY18 | $426.6K | −$356.9K |
| FY17 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | - | - |
| FY24 | 21.4% | −1563.3% | −2472.9% |
| FY23 | 79.1% | −2881.4% | −2479.8% |
| FY22 | 59.8% | −1477.1% | −1456.7% |
| FY21 | 69% | −1073.5% | −1100.2% |
| FY20 | 81.3% | −580.9% | −685.9% |
| FY19 | 17.8% | −1098.4% | −1121.3% |
| FY18 | 74% | −121.6% | −83.7% |
| FY17 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$3.8M |
| FY24 | - |
| FY23 | - |
| FY22 | −$5.1M |
| FY21 | −$4.2M |
| FY20 | - |
| FY19 | −$1.3M |
| FY18 | −$509K |
| FY17 | - |
- Nexentis Technologies
- Healthcare median
Show the numbers
| Year | Nexentis Technologies | Healthcare median |
|---|---|---|
| FY25 | - | −66.4% |
| FY24 | −2472.9% | −87% |
| FY23 | −2479.8% | −128.5% |
| FY22 | −1456.7% | −143.6% |
| FY21 | −1100.2% | −137.7% |
| FY20 | −685.9% | −134.3% |
| FY19 | −1121.3% | −125.9% |
| FY18 | −83.7% | −172.7% |
| FY17 | - | −166.7% |
News
No stories filed under Nexentis Technologies yet - coverage appears here as the news feed clusters it.